HCA Healthcare, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 58.75B | 60.23B | 64.97B | 70.60B | 75.60B | 7.1% | |
| Cost of Revenue | (36.26B) | (37.06B) | (39.39B) | (41.92B) | (44.23B) | 5.5% | |
Gross Profit | 22.49B | 23.18B | 25.58B | 28.68B | 31.37B | 9.4% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (26.78B) | (27.68B) | (29.49B) | (31.17B) | (8.00B) | -74.3% | |
| General & Administrative | (26.78B) | (27.68B) | (29.49B) | (31.17B) | (8.00B) | -74.3% | |
| Depreciation & Amortization | (2.85B) | (2.97B) | (3.08B) | (3.31B) | (3.52B) | 6.4% | |
Operating Income (EBIT) | 9.68B | 9.05B | 9.63B | 10.55B | 11.96B | 13.4% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (1.53B) | (1.74B) | (1.94B) | (2.06B) | (2.25B) | 9.1% | |
| Other Income/Expenses (Net) | 155.00M | -473.00M | -1.92B | -2.02B | -2.13B | 5.4% | |
Income Before Tax | 9.83B | 8.58B | 7.71B | 8.52B | 9.83B | 15.4% | |
| Income Tax Expense | (2.11B) | (1.75B) | (1.61B) | (1.87B) | (2.05B) | 9.9% | |
Net Income | 6.96B | 5.64B | 5.24B | 5.76B | 6.78B | 17.8% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $22 | $19 | $19 | $22 | $29 | 28.5% | |
| Weighted Avg Shares Outstanding | 323.31M | 290.35M | 272.40M | 258.60M | 230.71M | -10.8% | |
| Weighted Avg Shares Outstanding (Diluted) | 328.75M | 294.67M | 276.41M | 261.81M | 230.71M | -11.9% | |
EBITDA | 14.25B | 13.29B | 12.72B | 13.90B | 15.60B | 12.3% |
Explore HCA
HCA in the Healthcare
Large Cap